Overview

Quetiapine for Cocaine Use and Cravings

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to collect pilot data on whether quetiapine may be effective in the reduction of cocaine use and cravings in cocaine dependent individuals.
Phase:
Phase 4
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborator:
AstraZeneca
Treatments:
Cocaine
Quetiapine Fumarate